AHA: IV Antiplatelet Drug No CHAMPION (CME/CE)

ORLANDO (MedPage Today) The novel fast-acting intravenous antiplatelet agent cangrelor given at the time of PCI or stenting did not reduce the rate of death, MI, or ischemia-driven revascularization at 48 hours compared with clopidogrel (Plavix), results of two trials showed.

source : www.medpagetoday.com

Get 5 Books for 99 cents!
The most popular books at the most popular prices!

Home Income Profit System
You can make money working from the comfort of your own home!

CreditReport.com
Get your credit report and score in just seconds!

Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!

Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!

AHA: IV Antiplatelet Drug No CHAMPION (CME/CE)

Related News: